Latest Press Releases


Medigus Announces Pricing of Registered Direct

Medigus Ltd. today announced that it has entered into a definitive agreement with institutional investors providing for the issuance of 1,139,170 American depositary shares (ADS) at a purchase price per ADS of $0.67 in a registered direct offering.

Read more


Medigus Announces a Notice of Intention to Grant a European Patent for Its micro ScoutCam™ Microvisual Technology

Medigus Ltd. announced today that it has received a Notice of Intention to Grant a Patent from the European Patent Office (EPO) for its micro ScoutCam™ miniature camera technology.

Read more


Medigus Announces Third Quarter 2016 Financial Results

Medigus Ltd. today announced financial results for the third quarter ended September 30, 2016.

Read more





Medigus Announces Pricing of $1.47 Million Registered Direct Offering

Medigus entered into definitive securities purchase agreements with two institutional investors.

Read more


Medigus Announces Second Quarter 2016 Financial Results

Medigus Ltd. today announced financial results for the second quarter ended June 30, 2016.

Read more


Medigus Receives First Purchase Order From The Johns Hopkins Hospital for Its MUSETM System

World renowned healthcare institution purchases its first MUSE console and device to offer GERD patients a minimally-invasive treatment option

Read more


Medigus’ MUSE™ Continues to Gain Clinical Adoption in the U.S.

Innovative technology allows physicians to perform transoral fundoplication for effective, long-term treatment of acid reflux and improve patients’ GERD-related quality of life

Read more


Medigus Announces The Global Commercial Launch of The Next Generation of The MUSE™ System for the Long-term Treatment of GERD

Physicians can benefit from the latest technological advancements in microvisual, ultrasonic and endostapling to perform transoral fundoplication more effectively with the latest generation of the MUSE system

Read more


Medigus Announces First Quarter 2016 Financial Results

Medigus Ltd. today announced financial results for the first quarter ended March 31, 2016.

Read more




Medigus to Present at the 28th Annual ROTH Conference

CEO Chris Rowland to Present on March 14, 2016 at 8:00 a.m. PDT.

Read more


Medigus’ MUSE System Continues to Gain Clinical Adoption in the U.S. and Europe, With Number of Procedures Up Three-Fold Over Same Period Last Year

Top gastroenterologists showcase the benefits of using the MUSE system for transoral fundoplication, a leading procedure for the treatment of GERD. More than 200 procedures have been performed globally using MUSE.

Read more


Medigus to Begin Clinical Study in China for CFDA Regulatory Clearance

Medigus receives first purchase order from Golden Grand-Medical Instruments Ltd. to advance commercial agreement - Study results to be used for CFDA regulatory clearance process

Read more


Medigus Receives Commercial Order for micro ScoutCam™ from Leading Israeli Industrial Company

Medigus Ltd. received an initial commercial order in the amount of $118,000 from one of Israel’s leading industrial companies. 

Read more


Medigus Announces Third Quarter Financial Results

More than 40 leading, global hospitals are trained and perform procedures using the MUSE™ system - More than five times the number of procedures conducted using the MUSE system over last year.

Read more

Click here for the complete Medigus press release archive >